The company is exposed to risks associated with raw materials, including inflationary pressures and potential supply disruptions, which could negatively impact operations and profit margins. It relies on external manufacturers for current and future product candidates, potentially affecting commercialization timelines and competitive positioning. Strategic partners involved in collaboration arrangements include Lilly, Janssen, Takeda, and Johnson & Johnson. These partnerships may involve milestone payments, royalties, or potential acquisition scenarios.
Ac Immune Sa's Comment on Supply Chain
The company is exposed to risks associated with raw materials, including inflationary pressures and potential supply disruptions, which could negatively impact operations and profit margins. It relies on external manufacturers for current and future product candidates, potentially affecting commercialization timelines and competitive positioning. Strategic partners involved in collaboration arrangements include Lilly, Janssen, Takeda, and Johnson & Johnson. These partnerships may involve milestone payments, royalties, or potential acquisition scenarios.
Sources:
Ac Immune Sa's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Ac Immune Sa’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
